Glymphatic Pathway in Brain Imaging

NCT05035251 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-11-22

No results posted yet for this study

Summary

To investigate the pathways of Gadolinium-based contrast agent (GBCA) in different brain compartments and evaluate correlations of GBCA enhancement with specific diseases.

Conditions

  • Glymphatic System

Sponsors & Collaborators

  • Paracelsus Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2024-11-11
Completion
2024-12-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05035251 on ClinicalTrials.gov